ES8101551A1 - Un procedimiento para preparar nuevas 4-arilpiperinas. - Google Patents

Un procedimiento para preparar nuevas 4-arilpiperinas.

Info

Publication number
ES8101551A1
ES8101551A1 ES486425A ES486425A ES8101551A1 ES 8101551 A1 ES8101551 A1 ES 8101551A1 ES 486425 A ES486425 A ES 486425A ES 486425 A ES486425 A ES 486425A ES 8101551 A1 ES8101551 A1 ES 8101551A1
Authority
ES
Spain
Prior art keywords
alkyl
arylpiperidines
tetra
production
pharmaceutical preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES486425A
Other languages
English (en)
Other versions
ES486425A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of ES8101551A1 publication Critical patent/ES8101551A1/es
Publication of ES486425A0 publication Critical patent/ES486425A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

PROCEDIMIENTO DE OBTENCION DE 4-ARILPIPERIDINAS. CONSISTE EN HAER REACCIONAR UNA SAL DE IMINIO DE FORMULA GENERAL (I) CON UN REACTIVO DE ALQUILURO DE 1 A 5 ATOMOS DE CARBONO. OPCIONALMENTE, SE SOMETE AL COMPUESTO OBTENIDO (II) A DES-ETERIFICACION. *FORMULA* LOS PRODUCTOS DE PARTIDA SON 4-ARILPIPERIDINAS 1, 3, 4-TRISUSTITUIDAS, TANTO EN FORMA CIS COMO TRANS; PARA LA OBTENCION DEL PRODUCTO, SE PREPARA UNA MEZCLA RACEMICA. OPCIONALMENTE, LOS RACEMATOS PUEDEN SEPARARSE POR CRISTALIZACION FRACCIONADA Y CROMATOGRAFIA. ANALGESICOS.
ES486425A 1978-11-29 1979-11-28 Un procedimiento para preparar nuevas 4-arilpiperinas. Granted ES486425A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/965,137 US4284635A (en) 1978-11-29 1978-11-29 Analgesic 1,2,4,5-tetra-alkyl-4-arylpiperidines

Publications (2)

Publication Number Publication Date
ES8101551A1 true ES8101551A1 (es) 1980-12-16
ES486425A0 ES486425A0 (es) 1980-12-16

Family

ID=25509504

Family Applications (2)

Application Number Title Priority Date Filing Date
ES486425A Granted ES486425A0 (es) 1978-11-29 1979-11-28 Un procedimiento para preparar nuevas 4-arilpiperinas.
ES493915A Granted ES493915A0 (es) 1978-11-29 1980-07-31 Un procedimiento para preparar una sal de tetrahidropiridi- nio

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES493915A Granted ES493915A0 (es) 1978-11-29 1980-07-31 Un procedimiento para preparar una sal de tetrahidropiridi- nio

Country Status (26)

Country Link
US (1) US4284635A (es)
EP (1) EP0013078A3 (es)
JP (1) JPS5573657A (es)
KR (1) KR830001214A (es)
AR (1) AR224138A1 (es)
AT (1) ATA750879A (es)
AU (1) AU529136B2 (es)
BE (1) BE880220A (es)
CA (1) CA1121357A (es)
DD (1) DD147537A5 (es)
DK (1) DK504979A (es)
EG (1) EG14137A (es)
ES (2) ES486425A0 (es)
FI (1) FI793663A (es)
FR (2) FR2442836A1 (es)
GB (1) GB2038812B (es)
GR (1) GR72292B (es)
HU (1) HU178532B (es)
IL (1) IL58793A0 (es)
IT (1) IT1126406B (es)
LU (1) LU81923A1 (es)
PH (1) PH15420A (es)
PL (1) PL123672B1 (es)
PT (1) PT70486A (es)
SU (1) SU967275A3 (es)
ZA (1) ZA796336B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5212183A (en) * 1981-11-14 1993-05-18 Basf Aktiengesellschaft 4-(p-tert.-butylphenyl)-3-methylpiperidines substituted at the nitrogen, their quaternary salts and their use as fungicides
US4485109A (en) * 1982-05-07 1984-11-27 E. I. Du Pont De Nemours And Company 4-Aryl-4-piperidinecarbinols
US4581456A (en) * 1983-09-21 1986-04-08 Eli Lilly And Company Processes for preparing picenadol precursors and novel intermediates thereof
ZW10287A1 (en) * 1986-07-15 1988-01-13 Hoffmann La Roche Tetrahydronaphthaline and indane derivatives
EP0299549A3 (en) * 1987-07-09 1989-02-08 Duphar International Research B.V Tertiary 2,5-dialkyl-3-phenyl-piperidine derivatives having opiate-antagonistic activity
CA1337418C (en) * 1988-03-28 1995-10-24 Engelbert Ciganek 4-aryl-4-piperiding (or pyrrolidine or hexahydroazepine) carbinols and heterocyclic analogs thereof
US5136040A (en) * 1991-02-26 1992-08-04 Eli Lilly And Company Preparation of substituted tetrahydropyridines
US5159081A (en) * 1991-03-29 1992-10-27 Eli Lilly And Company Intermediates of peripherally selective n-carbonyl-3,4,4-trisubstituted piperidine opioid antagonists
US5250542A (en) * 1991-03-29 1993-10-05 Eli Lilly And Company Peripherally selective piperidine carboxylate opioid antagonists
US5270328A (en) * 1991-03-29 1993-12-14 Eli Lilly And Company Peripherally selective piperidine opioid antagonists
GB9912411D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912410D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912417D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912415D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912416D0 (en) * 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912413D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2892842A (en) * 1959-06-30 Their preparation
US2956058A (en) * 1957-08-19 1960-10-11 Lilly Co Eli Novel substituted piperidines and pyrrolidines
US3043845A (en) * 1958-12-29 1962-07-10 Abbott Lab Phenylmethylpiperidine derivatives
US3080372A (en) * 1960-03-25 1963-03-05 Res Lab Dr C Janssen 1-aroylalkyl-4-arylpiperidine derivatives
NL123743C (es) * 1963-09-18
BE720927A (es) * 1967-09-27 1969-03-03
US3936468A (en) * 1969-10-27 1976-02-03 Sumitomo Chemical Company, Ltd. Phenylbutanol derivatives
GB1403942A (en) * 1973-04-05 1975-08-28 Ciba Geigy Ag Piperidine derivatives
AR206937A1 (es) * 1974-09-06 1976-08-31 Lilly Co Eli Procedimiento para preparar compuestos de 1-sustituido-4-alquil-4-fenil-piperidina
US4115400A (en) * 1976-05-27 1978-09-19 Eli Lilly And Company 1-Azoniabicyclo[3.1.0]hexanes
ZA777356B (en) * 1976-12-17 1979-01-31 Rohm & Haas Arthropod repellents

Also Published As

Publication number Publication date
ZA796336B (en) 1981-06-24
EG14137A (en) 1983-09-30
BE880220A (fr) 1980-05-23
EP0013078A3 (en) 1980-10-01
FR2442836A1 (fr) 1980-06-27
GB2038812B (en) 1983-01-06
PT70486A (en) 1979-12-01
EP0013078A2 (en) 1980-07-09
GR72292B (es) 1983-10-17
PL123672B1 (en) 1982-11-30
AU5310079A (en) 1980-05-29
IT7927614A0 (it) 1979-11-27
JPS5573657A (en) 1980-06-03
LU81923A1 (fr) 1980-04-22
HU178532B (en) 1982-05-28
AR224138A1 (es) 1981-10-30
PH15420A (en) 1983-01-07
IL58793A0 (en) 1980-02-29
CA1121357A (en) 1982-04-06
ATA750879A (de) 1983-03-15
FR2442836B1 (es) 1983-07-29
KR830001214A (ko) 1983-04-29
IT1126406B (it) 1986-05-21
ES8200664A1 (es) 1981-11-16
FI793663A (fi) 1980-05-30
FR2453154A1 (fr) 1980-10-31
PL219885A1 (es) 1980-12-01
DD147537A5 (de) 1981-04-08
FR2453154B1 (es) 1983-05-27
SU967275A3 (ru) 1982-10-15
ES486425A0 (es) 1980-12-16
US4284635A (en) 1981-08-18
ES493915A0 (es) 1981-11-16
DK504979A (da) 1980-05-30
AU529136B2 (en) 1983-05-26
GB2038812A (en) 1980-07-30

Similar Documents

Publication Publication Date Title
ES8200664A1 (es) Un procedimiento para preparar una sal de tetrahidropiridi- nio
HUT37780A (en) Process for producing n-/4-piperidyl/-substituted bicyclic condensed 2-imidazolyl-amine derivatives and pharmaceutical compositions containing them as active agents
YU42116B (en) Process for obtaining ethanol amine derivatives
HUT50316A (en) Process for production of 1-phenyl-3-naphthyl-oxy-propanamines and pharmaceutical preparations containing them
HUT49889A (en) Process for producing acyl derivatives
GB8826595D0 (en) Active compounds
JO1617B1 (en) Modern 2-amino-tetraline-8 compounds
HUT46895A (en) Process for production of new 5-lipoxigenase bicyclic compounds with inhibiation effect
YU67487A (en) Process for preparing 10,11,12,13-tetrahydro derivative of tilozine
DE3063288D1 (en) Paromomycin derivatives, a process for the preparation thereof and therapeutical composition containing them
HUT46686A (en) Process for producing quinoline-carboxylic acid derivatives
RO87707B (ro) Procedeu pentru prepararea unor saruri de piridiniu
ES8302733A1 (es) Un procedimiento para preparar nuevos derivados de antraci- clina
AU2110088A (en) Novel derivatives of the oxime of 1,2,5,6-tetrahydropyridin-3-carboxaldehyde, the process for their preparation, their use as medicaments and the compositions containing them
ES8705464A1 (es) Un procedimiento para la preparacion de nuevos peptidos.
ES8101646A1 (es) Un procedimiento para producir un compuesto opticamente ac- tivo
ES8200689A1 (es) Un procedimiento para la produccion de analogos de cefalosporina.
HUT43612A (en) Process for production of new derivatives of peneme and medical preparatives containing thereof
ES8405372A1 (es) Un procedimiento para preparar un enantiomero puro de un fenilazacicloalcano sustituido.
HUT39731A (en) Process for preparing arphamenine derivatives and pharmaceutical compositions containing such compounds
ES2004255A6 (es) Procedimiento de preparar compuestos del tipo de las piracinas y analogos.
PT70097A (en) Process for preparing lactate salts of l- and d,l-glaucineand pharmaceutical compositions thereof having antitussiveand analgesic properties
JO1652B1 (en) New compounds for local anesthesia and a way to prepare them
ES465515A1 (es) Procedimiento para la obtencion de derivados de acidos 3,3'-triaril-metanodicarboxilicos.